Infection fongique invasive en oncologie et hématologie pédiatrique: analyse de la littérature et étude médicoéconomique des coûts de prise en charge = Invasive fungal infections in oncology and haematology unit care: Review of literature and costs analysisLECOINTRE, R; BLEYZAC, N.Annales pharmaceutiques françaises. 2011, Vol 69, Num 4, pp 214-220, issn 0003-4509, 7 p.Article

High-performance liquid chromatographic determination of ganciclovir nucleotides in human myocardial tissueBLEYZAC, N; BOULIEU, R.Journal of chromatography. Biomedical applications. 1994, Vol 658, Num 1, pp 173-176, issn 0378-4347Article

Rapid and sensitive high-performance liquid chromatographic method for busulfan assay in plasmaBLEYZAC, N; BAROU, P; AULAGNER, G et al.Journal of chromatography. B, Biomedical sciences and applications. 2000, Vol 742, Num 2, pp 427-432, issn 1387-2273Article

Peut-on utiliser une méthode bayésienne pour constituer une population pharmacocinétique en deux étapes ? = Can we use a bayesian method to build a pharmacokinetic population in two steps?CABELGUENNE, D; BLEYZAC, N; PIVOT, C et al.Thérapie (Paris). 2000, Vol 55, Num 2, pp 277-282, issn 0040-5957Article

Modified high-performance liquid chromatographic method for the determination of ganciclovir in plasma from patients with severe renal impairmentBOULIEU, R; BLEYZAC, N; FERRY, S et al.Journal of chromatography. Biomedical applications. 1991, Vol 571, Num 1-2, pp 331-333, issn 0378-4347Article

Intérêt clinique de l'adaptation des posologies du busulfan et de la ciclosporine chez des enfants greffés de moelle osseuse = Busulfan and cycosporin in bone graft childrenBERTOLLE, V; MARTIN, P; BLEYZAC, N et al.Annales pharmaceutiques françaises. 2004, Vol 62, Num 3, pp 165-176, issn 0003-4509, 12 p.Article

Les anesthésiques généraux = General anaestheticsLENOIR, A; CHARBONNEL, J. F; BLEYZAC, N et al.Lyon pharmaceutique. 1994, Vol 45, Num 6, pp 351-366, issn 0024-7804Article

Pharmacokinetics of ganciclovir in heart transplant patients undergoing continuous venovenous hemodialysisBOULIEU, R; BASTIEN, O; BLEYZAC, N et al.Therapeutic drug monitoring. 1993, Vol 15, Num 2, pp 105-107, issn 0163-4356Conference Paper

Les antiparkinsoniens = Antiparkinson agentsCHARBONNEL, J. F; BLEYZAC, N; LENOIR, A et al.Lyon pharmaceutique. 1993, Vol 44, Num 6, pp 367-377, issn 0024-7804Article

Augmentation de la consommation d'hypnotiques en gériatrie malgré le décret d'Octobre 1991 = Increased hypnotics consumption in geriatrics despitie the decree dated October 1991ONEN, F; BLEYZAC, N; MAIRE, P et al.La Revue de gériatrie. 1997, Vol 22, Num 7, pp 443-446, issn 0397-7927Article

New sensitive assay of vancomycin in human plasma using high-performance liquid chromatography and electrochemical detectionFAVETTA, P; GUITTON, J; BLEYZAC, N et al.Journal of chromatography. B, Biomedical sciences and applications. 2001, Vol 751, Num 2, pp 377-382, issn 1387-2273Article

Pharmacokinetics of ganciclovir in patients undergoing continuous venovenous hemodialysisBOULIEU, R; BLEYZAC, N; BASTIEN, O et al.European journal of drug metabolism and pharmacokinetics. 1994, pp 105-107, issn 0378-7966, NSConference Paper

Efficacité et tolérance de la lacidipine dans le traitement de l'hypertension artérielle en onco-hématologie pédiatrique = Lacidipine efficacy and safety for high blood pressure treatment in pediatric oncohematologyBERNARD, E; MIALOU, V; DONY, A et al.Archives de pédiatrie (Paris). 2014, Vol 21, Num 10, pp 1101-1105, issn 0929-693X, 5 p.Article

Influence of underlying disease on busulfan disposition in pediatric bone marrow transplant recipients : A nonparametric population pharmacokinetic studyBERTHOLLE-BONNET, V; BLEYZAC, N; GALAMBRUN, C et al.Therapeutic drug monitoring. 2007, Vol 29, Num 2, pp 177-184, issn 0163-4356, 8 p.Article

L'érythromycine responsable d'une intoxication sévère par la digoxine dans un service de réanimation néonatale = Erythromycin-induced digoxin toxicity in a neonatal intensive care unitCOUDRAY, S; JANOLY, A; BELKACEM-KAHLOULI, A et al.Journal de pharmacie clinique (Paris). 2001, Vol 20, Num 2, pp 129-131, issn 0291-1981Article

Utilisation d'une interaction médicamenteuse avec l'acide folinique dans le traitement d'une intoxication iatrogène à la fosphénytoïne = Treatment of a iatrogenic fosphenytoin overdose by using folinic acid drug interactionBELKACEM-KAHLOULI, A; AUDIBERT, L; MASSENAVETTE, B et al.Journal de pharmacie clinique (Paris). 2001, Vol 20, Num 4, pp 215-218, issn 0291-1981Article

Un nouvel outil d'évaluation de l'iatrogénie médicamenteuse, appliqué à l'hématologie pédiatrique = A new tool for assessment of medication errors applied to paediatric haematologyQUEUILLE, E; BLEYZAC, N; AURAY, J. P et al.Thérapie (Paris). 2001, Vol 56, Num 6, pp 775-783, issn 0040-5957Article

Étude coût-efficacité de l'érythropoïétine ntion de l'anémie versus transfusion sanguine dans la prévention de l'anémie chez les enfants prématurés = Cost-effectiveness analysis of recombinant human epoietin and blood transfusion in the prevention of anemia of prematurilyRONDIER, E; BLEYZAC, N; GUY, B et al.Journal de pharmacie clinique (Paris). 1999, Vol 18, Num 1, pp 52-54, issn 0291-1981Conference Paper

Efficacy and plasma levels of ropivacaine for children : controlled regional analgesia following lower limb surgeryDUFLO, F; SAUTOU-MIRANDA, V; POUYAU, A et al.British Journal of Anaesthesia. 2006, Vol 97, Num 2, pp 250-254, issn 0007-0912, 5 p.Article

Antileukemic and long-term effects of two regimens with or without TBI in allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemiaDAI, Q. Y; SOUILLET, G; BERLIER, P et al.Bone marrow transplantation (Basingstoke). 2004, Vol 34, Num 8, pp 667-673, issn 0268-3369, 7 p.Article

Relationship between CsA trough blood concentration and severity of acute graft-versus-host disease after paediatric stem cell transplantation from matched-sibling or unrelated donorsMARTIN, P; BLEYZAC, N; SOUILLET, G et al.Bone marrow transplantation (Basingstoke). 2003, Vol 32, Num 8, pp 777-784, issn 0268-3369, 8 p.Article

Simple and rapid high-performance liquid chromatographic method for nelfinavir, M8 nelfinavir metabolite, ritonavir and saquinavir assay in plasmaJANOLYA, A; BLEYZAC, N; FAVETTA, P et al.Journal of chromatography. B, Biomedical sciences and applications. 2002, Vol 780, Num 1, pp 155-160, issn 1387-2273, 6 p.Article

Comparison of nonlinear mixed-effect and non-parametric expectation maximisation modelling for Bayesian estimation of carboplatin clearance in childrenPATOUX, A; BLEYZAC, N; BODDY, A. V et al.European journal of clinical pharmacology. 2001, Vol 57, Num 4, pp 297-303, issn 0031-6970Article

Assessment of acyclovir intraindividual pharmacokinetic variability during continuous hemofiltration, continuous hemodiafiltration, and continuous hemodialysisBLEYZAC, N; BAROU, P; MASSENAVETTE, B et al.Therapeutic drug monitoring. 1999, Vol 21, Num 5, pp 520-525, issn 0163-4356Article

Évaluation médico-économique du G-CSF dans la greffe de moelle osseuse allogénique en pédiatrie = Medico-economical evaluation of granulocyte colony-stimulating factor in children undergoing allogeneic bone marrow transplantationROCHEGUDE, S; BLEYZAC, N; COLOMBINI, N et al.Journal de pharmacie clinique (Paris). 1999, Vol 18, Num OCT, pp 60-61, issn 0291-1981, NSConference Paper